<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>PR.com Press Releases: Creative Biolabs News</title>
		<link>https://www.PR.com/</link>
		<description>Latest news releases from PR.com for Creative Biolabs.</description>
		<lastBuildDate>Tue, 13 Oct 2026 06:23:04 -0400</lastBuildDate>
		<copyright>&#169; 2026 PR.com</copyright>
		<ttl>60</ttl>
		<language>en-us</language>
		<image>
			<url>https://www.PR.com/images/logo_white.jpg</url>
			<title>PR.com Press Releases: Creative Biolabs News</title>
			<link>https://www.PR.com/</link>
			<width>68</width>
			<height>69</height>
			<description>PR.com provides press release distribution, and is a unique directory of businesses, products and services. Find full company profiles.</description>
		</image>
		<atom:link href="https://www.pr.com/rss/press-releases-2/474618.xml" rel="self" type="application/rss+xml" />
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/948570</guid>
			<title>Creative Biolabs Finds a Way Out to Vitalize Functional Antibody Development</title>
			<pubDate>Fri, 19 Sep 2025 09:17:20 -0400</pubDate>
			<description>Creative Biolabs introduces how functional antibody development and supply are shaping biotech solutions and demonstrates solutions and scholarship opportunities. [PR.com]</description>
			<link>https://www.pr.com/press-release/948570</link>
			<dc:creator>Creative Biolabs</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/924722</guid>
			<title>Creative Biolabs Shines at the 2024 NIH Research Festival: Showcasing Antibody Solutions</title>
			<pubDate>Fri, 08 Nov 2024 03:00:00 -0500</pubDate>
			<description>Creative Biolabs made a splash at the 2024 NIH Research Festival, held from Sept. 23–25, as they highlighted their groundbreaking work in antibody discovery and development. [PR.com]</description>
			<link>https://www.pr.com/press-release/924722</link>
			<dc:creator>Creative Biolabs</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/917001</guid>
			<title>Creative Biolabs Spearheads Innovative Live Biotherapeutics Against Gut Diseases</title>
			<pubDate>Sat, 03 Aug 2024 10:09:59 -0400</pubDate>
			<description>Creative Biolabs introduces innovative solutions for live biotherapeutics to empower scientists and pharmaceutical companies in their quest for groundbreaking therapies against gut diseases. [PR.com]</description>
			<link>https://www.pr.com/press-release/917001</link>
			<dc:creator>Creative Biolabs</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/912099</guid>
			<title>Creative Biolabs Opens Applications for the 2024 Scholarship Program</title>
			<pubDate>Sun, 19 May 2024 03:00:00 -0400</pubDate>
			<description>Creative Biolabs, a leading CRO, is proud to announce the opening of applications for its 2024 scholarship program. This initiative aims to provide financial assistance to students within the biotechnology industry, supporting their academic pursuits and research endeavors. [PR.com]</description>
			<link>https://www.pr.com/press-release/912099</link>
			<dc:creator>Creative Biolabs</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/910452</guid>
			<title>Creative Biolabs: Summarizing Malaria Infection Mechanisms and Introducing Biotherapeutic Discovery</title>
			<pubDate>Thu, 25 Apr 2024 03:00:00 -0400</pubDate>
			<description>Creative Biolabs introduced the discovery of biomolecular approaches targeting Plasmodium, aiming to assist academia and the pharmaceutical industry in relieving the malaria health crisis. [PR.com]</description>
			<link>https://www.pr.com/press-release/910452</link>
			<dc:creator>Creative Biolabs</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/907907</guid>
			<title>Creative Biolabs: Illuminate Neurological Disease Research and Therapy Development with Customized Animal Models</title>
			<pubDate>Fri, 15 Mar 2024 03:00:00 -0400</pubDate>
			<description>Creative Biolabs is proud to announce its new-year resolution to dive deeper into sourcing professional animal model solutions for neurological disorder studies. [PR.com]</description>
			<link>https://www.pr.com/press-release/907907</link>
			<dc:creator>Creative Biolabs</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/906835</guid>
			<title>Creative Biolabs Supplies Recombinant Antibodies for Pharmaceutical Breakthroughs</title>
			<pubDate>Wed, 28 Feb 2024 06:52:31 -0500</pubDate>
			<description>Creative Biolabs reaffirmed its dedication to supplying high-quality antibody reagents in 2024. [PR.com]</description>
			<link>https://www.pr.com/press-release/906835</link>
			<dc:creator>Creative Biolabs</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/901735</guid>
			<title>Booth Unveiling Soon: Creative Biolabs and Ingenious Antibody Products at AET US 2023</title>
			<pubDate>Thu, 07 Dec 2023 07:16:35 -0500</pubDate>
			<description>Creative Biolabs highlights its participation in the upcoming Antibody Engineering and Therapeutics US 2023 conference, taking place from December 13–16, 2023. The event will be held in San Diego. [PR.com]</description>
			<link>https://www.pr.com/press-release/901735</link>
			<dc:creator>Creative Biolabs</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/899155</guid>
			<title>Creative Biolabs Unveils ADC Services, Igniting Excitement in the Biotech Industry</title>
			<pubDate>Sun, 29 Oct 2023 10:23:40 -0400</pubDate>
			<description>Creative Biolabs, a prominent provider of groundbreaking biotechnology solutions, proudly announced the expansion of its antibody-drug conjugate (ADC) business with the introduction of novel services.  In response to the escalating demand for precision therapies, ADCs have emerged as a promising and efficacious treatment modality, which integrate the specificity of monoclonal antibodies with potent cytotoxic drugs, [PR.com]</description>
			<link>https://www.pr.com/press-release/899155</link>
			<dc:creator>Creative Biolabs</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/886371</guid>
			<title>Creative Biolabs: Going Above and Beyond to Advance Immunology Discovery</title>
			<pubDate>Wed, 10 May 2023 03:00:00 -0400</pubDate>
			<description>Creative Biolabs updated strategies in order to help achieve success in immunotherapy discovery. [PR.com]</description>
			<link>https://www.pr.com/press-release/886371</link>
			<dc:creator>Creative Biolabs</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/883435</guid>
			<title>Creative Biolabs Provides Full-Fledged Solutions for Progressive Exosome Research</title>
			<pubDate>Fri, 14 Apr 2023 10:51:16 -0400</pubDate>
			<description>A newly released market research reports on the prosperous future of exosome research. [PR.com]</description>
			<link>https://www.pr.com/press-release/883435</link>
			<dc:creator>Creative Biolabs</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/881030</guid>
			<title>Creative Biolabs Looks Forward to a Year of Prosperity for Exosome Studies</title>
			<pubDate>Wed, 08 Mar 2023 03:00:00 -0500</pubDate>
			<description>Creative Biolabs expressed hopes that further progress could be made in the field of exosome research. [PR.com]</description>
			<link>https://www.pr.com/press-release/881030</link>
			<dc:creator>Creative Biolabs</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/878297</guid>
			<title>Creative Biolabs Updated Solutions to Support the Intensive Research on Exosomes</title>
			<pubDate>Sat, 11 Feb 2023 09:24:37 -0500</pubDate>
			<description>A recent market report reveals the huge potential of exosome research, which is gaining mounting research fever across the industry. [PR.com]</description>
			<link>https://www.pr.com/press-release/878297</link>
			<dc:creator>Creative Biolabs</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/875390</guid>
			<title>Novel Melanoma Diagnostic Tool: MicroRNAs-Associated Extracellular Vesicles Endorsed by Creative Biolabs</title>
			<pubDate>Wed, 21 Dec 2022 03:00:00 -0500</pubDate>
			<description>Creative Biolabs identifies a suite of exosome services to advance basic research based on microRNAs-associated extracellular vesicles as novel diagnostic tools for melanoma. [PR.com]</description>
			<link>https://www.pr.com/press-release/875390</link>
			<dc:creator>Creative Biolabs</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/838023</guid>
			<title>Updated Creative Biolabs Scholarship Program Specialized for Students in Sciences</title>
			<pubDate>Thu, 10 Jun 2021 03:00:00 -0400</pubDate>
			<description>Lately, Creative Biolabs released its scholarship program for the year 2021. As an expert biotechnology CRO specialized in the field of antibody production and engineering, Creative Biolabs is always willing to support young and ambitious talents in the medical and science-related fields.  The 2021 Creative Biolabs Scholarship Program mainly targets undergraduate, graduate, or Ph.D. students who are working on science or [PR.com]</description>
			<link>https://www.pr.com/press-release/838023</link>
			<dc:creator>Creative Biolabs</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/538174</guid>
			<title>Creative Biolabs Collaborates with Creative Biomart to Offer Bio-Similar Cell Lines for the Production of Recombinant Proteins</title>
			<pubDate>Thu, 23 Jan 2014 03:00:00 -0500</pubDate>
			<description>Creative Biolabs and Creative Biomart collaboratively launch the bio-similar cells lines, which aim to promote and facilitate the research in biotechnology led to the production of recombinant proteins, therapeutic MAb etc. with views to its clinical application. [PR.com]</description>
			<link>https://www.pr.com/press-release/538174</link>
			<dc:creator>Creative Biolabs</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/529155</guid>
			<title>Creative Biolabs Announces the Start of Year-End Promotion for Its Full Monoclonal Antibody Sequencing</title>
			<pubDate>Wed, 27 Nov 2013 11:54:00 -0500</pubDate>
			<description>Creative Biolabs today announces that it will begin to accept the end of year promotion for its full mAB sequencing services/products. [PR.com]</description>
			<link>https://www.pr.com/press-release/529155</link>
			<dc:creator>Creative Biolabs</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/526176</guid>
			<title>Creative Biolabs Launches New Service—Membrane Protein Production</title>
			<pubDate>Fri, 08 Nov 2013 03:00:00 -0500</pubDate>
			<description>Creative Biolabs expands its service lines to membrane protein production based on its unique MemProTM technique. [PR.com]</description>
			<link>https://www.pr.com/press-release/526176</link>
			<dc:creator>Creative Biolabs</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/517396</guid>
			<title>Creative Biolabs Designs Novel Techniques to Solve Problems Met in Dimerization of ScFv/Fab</title>
			<pubDate>Sun, 22 Sep 2013 03:00:00 -0400</pubDate>
			<description>In designing strategies for dimerization of antibody fragments, Creative Biolabs has developed novel techniques to solve tricky issues, such as stability and homogeneity of the dimers, resistance to proteolytic cleavage during in vivo assembly, efficient production of preferably soluble protein, easy gene engineering steps, great expression level in bacterial cells, good activity and specificity maintenance, thermal [PR.com]</description>
			<link>https://www.pr.com/press-release/517396</link>
			<dc:creator>Creative Biolabs</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/514562</guid>
			<title>Creative Biolabs Launches &quot;One-Stop&quot; Phage Display Services</title>
			<pubDate>Sun, 08 Sep 2013 03:00:00 -0400</pubDate>
			<description>After services expansion, Creative Biolabs is delighted to announce the launch of “one-stop” phage display services for researchers and institutions. [PR.com]</description>
			<link>https://www.pr.com/press-release/514562</link>
			<dc:creator>Creative Biolabs</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/512637</guid>
			<title>Creative Biolabs Works with UEC for Commercial Phage Display Technology</title>
			<pubDate>Fri, 30 Aug 2013 03:00:00 -0400</pubDate>
			<description>Creative Biolabs works with UEC for a bioscience and technology program. During the time, Creative Biolabs offers custom phage display construction and screening services by signing a custom service contract for commercial pre-made library. [PR.com]</description>
			<link>https://www.pr.com/press-release/512637</link>
			<dc:creator>Creative Biolabs</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/512364</guid>
			<title>Creative Biolabs Establishes Solid Platform for DNA Sequencing of Monoclonal Antibodies</title>
			<pubDate>Thu, 29 Aug 2013 03:00:00 -0400</pubDate>
			<description>Creative BioLabs has established a solid platform for DNA sequencing of both IgG and IgM types of monoclonal antibodies produced by mouse and rat hybridoma cell lines. [PR.com]</description>
			<link>https://www.pr.com/press-release/512364</link>
			<dc:creator>Creative Biolabs</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/505307</guid>
			<title>Creative Biolabs Expands Custom Immunoassay Kits for Quantitative Detection</title>
			<pubDate>Fri, 26 Jul 2013 03:00:00 -0400</pubDate>
			<description>Corresponding to markets needs, Creative Biolabs decides to expand its original custom immunoassay development services. [PR.com]</description>
			<link>https://www.pr.com/press-release/505307</link>
			<dc:creator>Creative Biolabs</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/504124</guid>
			<title>Creative Biolabs Launches Hi-AffinityTM Technology Platform for the Development of Human Antibodies</title>
			<pubDate>Sat, 20 Jul 2013 03:00:00 -0400</pubDate>
			<description>The human antibodies derived from the novel technological platform have the highest affinity ever enabled by an in vitro antibody production technology. [PR.com]</description>
			<link>https://www.pr.com/press-release/504124</link>
			<dc:creator>Creative Biolabs</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/503656</guid>
			<title>Creative Biolabs Announces Featured Protein Array Services to Facilitate Researchers’ Study</title>
			<pubDate>Thu, 18 Jul 2013 03:00:00 -0400</pubDate>
			<description>Protein arrays make it possible to gain the high-throughput, parallel analysis of thousands of bio-reactions, including protein-antibody, protein-protein, protein-ligand, protein-drug and enzyme-substrate interactions. Creative Biolabs offers a series of high-density human, E. coli, SARS and Herpes protein arrays as well as custom staining services on the arrays. [PR.com]</description>
			<link>https://www.pr.com/press-release/503656</link>
			<dc:creator>Creative Biolabs</dc:creator>
		</item>
	</channel>
</rss>